Published in Lab Business Week, November 26th, 2006
The study is the first of its kind to examine the costs of such prescription drug abuse from a societal perspective.
Analysis Group, a leading economic consulting firm, co-authored the study alongside researchers from Johnson & Johnson Pharmaceutical Services, Outcomes Research (Ortho-McNeil Janssen Scientific Affairs), and Nathaniel Katz, MD, MS, of Tufts University School of Medicine and Analgesic Research. Leading the Analysis Group team were Howard Birnbaum and Alan White, vice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week